
The Company collaborates with Jiangsu Yike Regenerative Medicine Technology Co., Ltd. Yike Medical Center is a duly lice...
A medical diagnostic chip is a medical device comprising a biosensor, a mixed-signal integrated circuit, and bio-packagi...

Official Channels for Corporate Communications and Disclosure Visionary Holding Inc. (NASDAQ: GV) hereby annou...

Meeting to Consider Reverse Stock Split, Board Expansion, Annual Financial Statements and Other Corporate Governance Mat...

Company Highlights Strategic Transformation Toward Biotechnology, Regenerative Medicine and Stem Cell Technologies [Toro...
TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) — Visionary Holdings Inc. (NASDAQ: GV) (“Visionary” or the “Company”) anno...
Toronto – Visionary Holdings Inc. (Nasdaq: GV, hereinafter referred to as the “Company”) released its 20-F A...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUA...
Toronto, Canada – November 18, 2025 — Visionary Holdings Inc. (“GV” or the “Company”) (Nasdaq: GV), a technology-driven ...
At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. (hereinafter referred to as the “Co...
+1 9053051881
CopyCopied445 Apple Creek Blvd., unit 217, Marham, Ontario, Canada, L3R 9X7
CopyCopied